|
National Stock Number(NSN): 6505-01-503-5293 (6505015035293, 015035293)
| NIIN: |
01-503-5293 |
Item Name: |
GLOBULIN,VACCINIA IMMUNE |
INC: |
34441
|
| FSC: |
6505
|
Assignment Date: |
Dec-20-2002 |
CRIT: |
X |
IIG: |
34441 |
| ISC: |
2 |
Date Standardized: |
Dec-20-2002 |
HMIC: |
P |
DODIC: |
|
| NSC: |
8 |
Cancellation Date: |
Apr-11-2022 |
PMIC: |
A |
FIIG: |
T088-D |
| ESD: |
|
Schedule B: |
3002.12.0030 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
4 |
Originator: |
KX |
ADPEC: |
|
RPDMRC: |
3 |
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
02-1924 |
89875
|
DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA |
H |
5 |
1 |
4 |
ZZ |
|
|
|
|
|
|
|
BB-IND 9141 |
1GFE1
|
DYNPORT VACCINE COMPANY LLC |
H |
5 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
BB-IND 9141 |
64616
|
DEFENSE MEDICAL STANDARDIZATION BOARD |
H |
3 |
2 |
4 |
ZZ |
|
|
|
|
|
|
|
NDC14310-2500-01 |
1GFE1
|
DYNPORT VACCINE COMPANY LLC |
H |
5 |
2 |
4 |
ZZ |
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
|
|
|
|
|
|
A |
$0.00 |
|
|
------- |
Apr-01-2021 |
H |
| DF |
SMS |
Y |
|
0 |
U |
1 |
F |
$0.01 |
VI |
|
------- |
Nov-01-2014 |
H |
| DN |
SMS |
Y |
|
0 |
U |
1 |
N |
$0.01 |
VI |
|
9B----- |
Nov-01-2014 |
H |
| DS |
SMS |
Y |
|
0 |
U |
1 |
D |
$0.01 |
VI |
|
------- |
Nov-01-2014 |
H |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 50ML |
000 |
|
|
|
| DA |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DF |
K |
U/I CONTAINS 50ML |
000 |
|
|
|
| DF |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
K |
U/I CONTAINS 50ML |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
K |
U/I CONTAINS 50ML |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AJUC |
AMERICAN HOSPITAL FORMULARY SERVICE CLASSIFICATION NUMBER |
800400 |
| CXCY |
PART NAME ASSIGNED BY CONTROLLING AGENCY |
VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN) |
| FEAT |
SPECIAL FEATURES |
INTRAVENOUS, HUMAN, 50 ML VIAL, STORE BETWEEN 2-8 DEG C; SUBJECT TO DAMAGE BY FREEZING |
| MDES |
MEDICAL DESIGNATION AND GRADE |
UNITED STATES PHARMACOPEIA |
| SUPP |
SUPPLEMENTARY FEATURES |
REQUISITIONS MUST BE AUTHORIZED IN ACCORDANCW WITH INDIVIDUAL MILITARY SERVICE DIRECTIVES TO USAMMA; FOR INTRAVENOUS USE ONLY |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| ZA01 |
|
Feb-13-2006 |
|
|
|
|
ZA |
ZA |
|